Additionally, several molecular signaling pathways, including the STAT3, AKT, and ERK pathways, are aberrantly activated in HCC, leading to the dysregulation of downstream target genes that control proliferation, survival, invasion, and stemness [30,31,32]. This evidence concerns the gene MAPK1 and hepatocellular carcinoma.